BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Savient Pharmaceuticals, Inc. 

One Tower Center, Fourteenth Floor

East Brunswick  New Jersey  08816  U.S.A.
Phone: 732-418-9300 Fax: 732-418-0570


SEARCH JOBS


Industry
Biotechnology






 Company News
Crealta Pharmaceuticals Announces Completion Of The Acquisition Of Substantially All Of The Assets Of Savient Pharmaceuticals, Inc. (SVNT) 1/10/2014 10:56:42 AM    More...
Savient Pharmaceuticals, Inc. (SVNT) Receives Approval From Bankruptcy Court To Sell Substantially All Assets To Crealta Pharmaceuticals 12/16/2013 7:09:47 AM    More...
Savient Pharmaceuticals, Inc. (SVNT) Agrees To Unload All Assets To Crealta Pharmaceuticals For $120.4 Million 12/11/2013 6:02:37 AM    More...
Savient Pharmaceuticals, Inc. (SVNT) Reaches Agreement On Use Of Cash Collateral 12/10/2013 11:05:06 AM    More...
Savient Pharmaceuticals, Inc. (SVNT) Receives Court Approval of Key "First Day" Motions 10/17/2013 9:45:23 AM    More...
Savient Pharmaceuticals, Inc. (SVNT) Files for Chapter 11, Seeks to Sell Assets for About $55 Million 10/15/2013 8:06:05 AM    More...
Savient Pharmaceuticals, Inc. (SVNT) Announces Abstract Related to KRYSTEXXA® Accepted for Presentation at ASN Kidney Week 2013 10/8/2013 6:49:38 AM    More...
Savient Pharmaceuticals, Inc. (SVNT) Announces Multiple Abstracts Related to KRYSTEXXA® to be Presented at the 2013 American College of Rheumatology/ARHP Annual Meeting 10/4/2013 6:44:22 AM    More...
Savient Pharmaceuticals, Inc. (SVNT) Reports Second Quarter 2013 Financial Results 8/14/2013 6:33:27 AM    More...
Savient Pharmaceuticals, Inc. (SVNT) Announces Formation of Office of the President 6/24/2013 9:07:24 AM    More...
12345678910...

//-->